Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is closely linked to obesity, type 2 diabetes and other metabolic disorders worldwide. Crocin is a carotenoid compound possessing various pharmacological activities. In the present study, we aimed to investigate the effect on fatty liver...
Main Authors: | Li Luo, Kai Fang, Xiaomeng Dan, Ming Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-018-0955-6 |
Similar Items
-
The Hypoglycemic and Renal Protection Properties of Crocin via Oxidative Stress-Regulated NF-κB Signaling in db/db Mice
by: Ye Qiu, et al.
Published: (2020-04-01) -
The effect of crocin supplementation on glycemic control, insulin resistance and active AMPK levels in patients with type 2 diabetes: a pilot study
by: Vahideh Behrouz, et al.
Published: (2020-07-01) -
Protective Effects of Crocin on Hepatic Steatosis in the Rats Fed with High Fat Diet
by: Darioush Mohajeri, et al.
Published: (2012-06-01) -
Salvianolic Acid B Ameliorates Hyperglycemia and Dyslipidemia in db/db Mice through the AMPK Pathway
by: Ming-Qing Huang, et al.
Published: (2016-12-01) -
Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
by: Liuran Li, et al.
Published: (2021-05-01)